Phase II pilot trial of preoperative high-dose chemotherapy in patients with malignant tumors of the upper gastrointestinal tract

International Journal of Oncology

Volumn 9, Issue 4, 1996, Pages 613-617

  Berdel, W E ^a   Heldmann, T ^a   Germer, C ^a   Wiedenmann, B ^a   Rosewicz, S ^a   Boese Landgraf, J ^a   Karavias, T ^a   Kreuser, E D ^a   Buhr, H J ^a   Thiel, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cancer of the gastroesophageal junction; esophageal cancer; gastric cancer; preoperative high dose chemotherapy; stem cell rescue

Indexed keywords

CARMUSTINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; MITOMYCIN;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MALE; MUCOSA INFLAMMATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STOMACH CARCINOMA;

EID: 0029839911     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.4.613     Document Type: Article

References (22)

1. Middleton G, Cunningham D: Current options in the management of gastrointestinal cancer. Ann Oncol 6 (Suppl 1): 17-26, 1995.
2. Kelsen D, Atiq OT: Therapy of upper gastrointestinal tract cancers. Curr Probl Cancer 5: 239-294, 1991.
3. Ajani JA, Mansfield PF, Ota DM: Potentially resectable gastric carcinoma: Current approaches to staging and preoperative therapy. World J Surg 19: 216-220, 1995.
4. Jäger E, Knuth A: Adjuvante und palliative Chemotherapie des Magenkarzinoms. Dtsch Med Wschr 120: 491-497, 1995.
5. Philip PA, Ajani JA: Has combined modality therapy improved the outlook in carcinoma of the esophagus? Oncology 8: 37-42, 1994.
6. Fagerberg J, Stockeld D, Lewensohn R: Combined treatment modalities in esophageal cancer. Acta Oncol 33: 439-450, 1994.
7. Armitage JO, Antman KH (eds.): High-dose cancer therapy: pharmacology, hematopoietins, stem cells. Williams & Wilkins, Baltimore, USA, 1992.
8. Berdel WE, Becher R, Edler L, Hanauske AR, Kerpel-Fronius S, Rauschning W, Schmoll HJ, Sindermann H: Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase I/II-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft. Onkologie 17: 311-338, 1994.
9. Wilke H, Preusser P, Fink U, Gunzer U, Meyer HJ, Meyer J, Siewert JR, Achterrath W, Lenaz L, Knipp H, Schmoll HJ: Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: A phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7: 1318-1326, 1989.
10. Klein HO, Wickramanayke PD, Dieterle F, Mohr R, Oerkermann H, Brock J, Beyer D, Gross R: Chemotherapieprotokoll zur Behandlung des metastasierenden Magenkarzinoms. Methotrexat, Adriamycin und 5-FluorouraciI. Dtsch Med Wschr 107: 1708-1712, 1982.
11. Gatzemeier U, Fasske E, Nowak U: Experimentelle und klinische Daten zur pulmonalen Toxizität von Mitomycin-C. Pneumologie 44: 201-203, 1990.
12. Cocconi G: Chemotherapy of advanced gastric carcinoma: To be completely rewritten? Ann Oncol 5: 8-11, 1994.
13. Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V, Brennan M: FAMTX versus etoposide, doxorubicin and cisplatin: A random assignment in gastric cancer. J Clin Oncol 10: 541-548, 1992.
14. Wright CD, Mathisen DJ, Wain JC, Grillo HC, Hilgenberg AD, Moncure AC, Carey RW, Choi NC, Daly M, Logan DL: Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction. Ann Thorac Surg 58: 1574-1579, 1994.
15. Rougier P, Lasser P, Ducreux M, Mahjoubi M, Bognel C, Elias D: Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol 5 (Suppl 3): 59-68, 1994.
16. Räth U, Flechtner H, Selbach J, Harjung H, Manegold C, Kabelitz K, Trux FA, Edler L, Schlag P, Queißer W: Etoposide, adriamycin and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'. Onkologie 13: 194-197, 1990.
17. Ajani JA, Roth JA, Ryan MB, Putnam JB, Pazdur R, Levin B, Gutterman JU, McMurtrey M: Preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 11: 22-28, 1993.
18. Suzuki T, Takenori O, Nagata M, Koide Y, Gunji Y, Nakajima K, Yokoyama T, Kashiwabara H, Isono K: High-dose chemotherapy with autologous bone marrow transplantation in the treatment of advanced gastric cancer. Cancer 72: 2537-2542, 1993.
19. Kessinger A: High-dose chemotherapy with autologous marrow transplantation for advanced gastrointestinal adenocarcinomas. Dig Dis 4: 203-207, 1986.
20. van der Wall E, Richel DJ, Holtenkamp MJ, Slaper-Cortenbach ICM, van der School CE, Dalesio O, Nopijen WJ, Schomagel JH, Rodenhuis S: Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: Effect of graft size. Ann Oncol 5: 795-802, 1994.
21. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, Blume KG: Granulocyte colony-stimulating factor 'mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81: 2031-2035, 1993.
22. O'Reilly S, Forastiere AA: Is surgery necessary with multimodality treatment of oesophageal cancer? (Editorial). Ann Oncol 6: 519-521, 1995.